BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

318 related articles for article (PubMed ID: 1977959)

  • 1. Immunolocalization of heparan sulfate proteoglycans to the prion protein amyloid plaques of Gerstmann-Straussler syndrome, Creutzfeldt-Jakob disease and scrapie.
    Snow AD; Wight TN; Nochlin D; Koike Y; Kimata K; DeArmond SJ; Prusiner SB
    Lab Invest; 1990 Nov; 63(5):601-11. PubMed ID: 1977959
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The presence of heparan sulfate proteoglycans in the neuritic plaques and congophilic angiopathy in Alzheimer's disease.
    Snow AD; Mar H; Nochlin D; Kimata K; Kato M; Suzuki S; Hassell J; Wight TN
    Am J Pathol; 1988 Dec; 133(3):456-63. PubMed ID: 2974240
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Heparan sulfate proteoglycan in diffuse plaques of hippocampus but not of cerebellum in Alzheimer's disease brain.
    Snow AD; Sekiguchi RT; Nochlin D; Kalaria RN; Kimata K
    Am J Pathol; 1994 Feb; 144(2):337-47. PubMed ID: 8311117
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Carbohydrate histochemistry of amyloid plaques in Gerstmann-Sträussler syndrome.
    Schumacher U; Kretzschmar HA; Tateishi J
    Eur J Basic Appl Histochem; 1991; 35(4):331-40. PubMed ID: 1801929
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The presence of complements in amyloid plaques of Creutzfeldt-Jakob disease and Gerstmann-Straussler-Scheinker disease.
    Ishii T; Haga S; Yagishita S; Tateishi J
    Appl Pathol; 1984; 2(6):370-9. PubMed ID: 6400466
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Amyloid plaques in Creutzfeldt-Jakob disease stain with prion protein antibodies.
    Kitamoto T; Tateishi J; Tashima T; Takeshita I; Barry RA; DeArmond SJ; Prusiner SB
    Ann Neurol; 1986 Aug; 20(2):204-8. PubMed ID: 3092727
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Toluidine blue-O staining of prion protein deposits.
    Sánchez A; Guzmán A; Ortiz A; Rembao D; Espinosa B; Zenteno E; Guevara J
    Histochem Cell Biol; 2001 Dec; 116(6):519-24. PubMed ID: 11810193
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Infectious proteins or prions. A new mechanism of disease].
    Benítez-Bribiesca L
    Gac Med Mex; 1998; 134(1):107-9. PubMed ID: 9658704
    [No Abstract]   [Full Text] [Related]  

  • 9. Differential binding of vascular cell-derived proteoglycans (perlecan, biglycan, decorin, and versican) to the beta-amyloid protein of Alzheimer's disease.
    Snow AD; Kinsella MG; Parks E; Sekiguchi RT; Miller JD; Kimata K; Wight TN
    Arch Biochem Biophys; 1995 Jun; 320(1):84-95. PubMed ID: 7793988
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Encephalopathy caused by prions].
    Michel B
    Rev Neurol (Paris); 1990; 146(1):1-11. PubMed ID: 2408126
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cerebral amyloid angiopathy with co-localization of prion protein and beta-amyloid in an 85-year-old patient with sporadic Creutzfeldt-Jakob disease.
    Paquet C; Privat N; Kaci R; Polivka M; Dupont O; Haïk S; Laplanche JL; Hauw JJ; Gray F
    Acta Neuropathol; 2008 Nov; 116(5):567-73. PubMed ID: 18551298
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunohistochemical localization of 14.3.3 zeta protein in amyloid plaques in human spongiform encephalopathies.
    Richard M; Biacabe AG; Streichenberger N; Ironside JW; Mohr M; Kopp N; Perret-Liaudet A
    Acta Neuropathol; 2003 Mar; 105(3):296-302. PubMed ID: 12557018
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gerstmann-Sträussler-Scheinker disease: immunohistological and experimental studies.
    Tateishi J; Kitamoto T; Hashiguchi H; Shii H
    Ann Neurol; 1988 Jul; 24(1):35-40. PubMed ID: 3046469
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Creutzfeldt-Jakob disease prion proteins in human brains.
    Bockman JM; Kingsbury DT; McKinley MP; Bendheim PE; Prusiner SB
    N Engl J Med; 1985 Jan; 312(2):73-8. PubMed ID: 3917302
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The epsilon isoform of 14-3-3 protein is a component of the prion protein amyloid deposits of Gerstmann-Sträussler-Scheinker disease.
    Di Fede G; Giaccone G; Limido L; Mangieri M; Suardi S; Puoti G; Morbin M; Mazzoleni G; Ghetti B; Tagliavini F
    J Neuropathol Exp Neurol; 2007 Feb; 66(2):124-30. PubMed ID: 17278997
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Altered expression and distribution of heparan sulfate proteoglycans in human gliomas.
    Steck PA; Moser RP; Bruner JM; Liang L; Freidman AN; Hwang TL; Yung WK
    Cancer Res; 1989 Apr; 49(8):2096-103. PubMed ID: 2522816
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A temporal and ultrastructural relationship between heparan sulfate proteoglycans and AA amyloid in experimental amyloidosis.
    Snow AD; Bramson R; Mar H; Wight TN; Kisilevsky R
    J Histochem Cytochem; 1991 Oct; 39(10):1321-30. PubMed ID: 1940305
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Creutzfeldt-Jakob disease patients with congophilic kuru plaques have the missense variant prion protein common to Gerstmann-Sträussler syndrome.
    Doh-ura K; Tateishi J; Kitamoto T; Sasaki H; Sakaki Y
    Ann Neurol; 1990 Feb; 27(2):121-6. PubMed ID: 2180366
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Creutzfeldt-Jakob disease(CJD) and Gerstmann-Sträussler-Scheinker syndrome(GSS)].
    Udaka F; Fujisawa M; Kameyama M
    Nihon Rinsho; 1997 Apr; 55(4):972-7. PubMed ID: 9103904
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human spongiform encephalopathy: the National Institutes of Health series of 300 cases of experimentally transmitted disease.
    Brown P; Gibbs CJ; Rodgers-Johnson P; Asher DM; Sulima MP; Bacote A; Goldfarb LG; Gajdusek DC
    Ann Neurol; 1994 May; 35(5):513-29. PubMed ID: 8179297
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.